Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Environmental Factors Instruct Lineage Choice Of Blood Progenitor Cells
The research team led by Dr. Timm Schroeder, stem cell researcher at Helmholtz Zentrum MÃønchen, has developed a new bioimaging method for observing the differentiation of hematopoietic progenitor cells (HPC) at the single-cell level. With this method the researchers were able to prove for the first time that not only cell-intrinsic mechanisms, but also external environmental factors such as growth factors can control HPC lineage choice directly. The findings, published in the current issue of the prestigious journal Science, provide an essential building block for understanding the molecular mechanisms of hematopoiesis and are an important prerequisite for optimizing therapeutic stem cell applications.

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved In Japan For The Treatment Of Bronchial Asthma In Adult Patients
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company"s country operation in Japan, has received marketing approval for ASMANEX TWISTHALER (mometasone furoate dry powder inhaler) for the treatment of bronchial asthma in adults.(1)
News of the day
Brain Changes Observed In Unimpaired Older Humans Could Be Early Warning Of Alzheimer's
New research has uncovered an early disruption in the process of memory formation in older humans who exhibit some early brain changes associated with Alzheimer"s disease (AD) but show little or no memory impairment. The work, published by Cell Press in the July 30th issue of the journal Neuron, sheds light on the role of amyloid protein in memory impairment and may lead to development of strategies for predicting and treating cognitive decline in individuals who are at-risk for AD.
Diagnostics

MEDEC Commends The Ontario Government's Decision To Make PET Scans More Accessible To Patients In The Province

MEDEC - Canada"s Medical Technology Companies - applauds the Ontario Government for its recent decision to add Positron Emission Tomography (PET) Technology to the services covered by the Ontario Health Insurance Plan (OHIP) thereby ensuring that Ontarians have access to PET technology. MEDEC Vice President Corporate Affairs, Lawrence Sereacki praised the actions of the Ontario government, noting that this is an opportune time for the government to modify its PET policy to help resolve the medical isotope dilemma and enhance the expeditious review and adoption of new technology for the benefit of patients. He added that MEDEC looks forward to working with the government and acting as a re to ensure smooth implementation of PET access for Ontarians. "PET scan technology is well recognized by Health Canada and others around the world" he said. "We are pleased that the government has decided to make this modern medical technology available to a wide cross section of Ontarians. Historically, Ontario had taken a decision to restrict PET scans. MEDEC had repeatedly stressed in the past that this restrictive access to PET technology has disadvantaged Ontario residents who needed access to PET scans for appropriate diagnosis and treatment and created a disparity between access to health care in Ontario versus other provinces. While applauding the province"s new step towards improving access to health technologies, MEDEC sees the need for the Ontario government to make additional changes to expeditiously assess and make modern technology more rapidly available to Ontario patients. Additionally, MEDEC recommends that the Ontario Government set up a Medical Device Technology Fund to finance technologies recommended by the Ontario Health Technology Advisory Committee (OHTAC) to improve patient access to advanced medical technologies and ensure hospitals and healthcare facilities offer advanced technologies that can save lives. MEDEC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009